Background: Frailty is a progressive geriatric syndrome characterized by decreased physiological reserve, reduced resilience to stressors, and increased risk of falls, disability, hospitalization, and mortality. Recent research has reframed frailty as a dynamic and potentially reversible condition. Physical activity (PA) is one of the most promising non-pharmacological strategies for its prevention and management. Aims: To summarize and critically evaluate current evidence on the role of physical activity in the development, prevention, and reversal of frailty in older adults, based on recent systematic and narrative reviews published between 2019 and 2024. Methods: This narrative evidence-based review synthesized data from systematic reviews and meta-analyses retrieved from PubMed, Scopus, Embase, Web of Science, and Cochrane CENTRAL (2019–2024). Studies including adults aged ≥60 years were analyzed, focusing on aerobic, resistance, balance, multicomponent, and mind–body exercise interventions. Outcomes included frailty incidence, functional capacity, cognition, and quality of life. Methodological rigor was assessed according to PRISMA and GRADE criteria reported by the original authors. Results: Higher levels of physical activity were consistently associated with an approximately 40–55% lower risk of developing frailty. Multicomponent exercise programs combining resistance, aerobic, and balance training produced the strongest and most consistent improvements in frailty status, gait speed, muscle strength, and cognitive performance. Biological mechanisms underlying these benefits include mitigation of sarcopenia, reduction of chronic inflammation and oxidative stress, improvement of mitochondrial efficiency, and regulation of anabolic hormones. Conclusions: Regular, structured, and individualized physical activity represents an evidence-based therapeutic strategy for preventing and reversing frailty in older adults. Integration of tailored multicomponent exercise programs into clinical and community care should be prioritized. Future research should focus on standardizing frailty and activity assessment, defining optimal dose–response relationships, and expanding evidence to diverse populations.